Membrane FasL as a Trigger for Pigmentary Glaucoma
Principal Investigator
Meredith Gregory-Ksander, PhD
Schepens Eye Research Institute of Massachusetts Eye and Ear
Boston, MA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
G2006054
Acknowledgement
Summary
Pigmentary glaucoma is one of the most common forms of secondary glaucoma. However, the underlying cause remains unclear. The DBA/2J mouse is an animal model of pigmentary glaucoma and provides us with a unique tool to study the causes of pigmentary glaucoma in order to design improved and targeted treatments. Pigmentary glaucoma in DBA/2J mice is caused when the iris starts to breakdown, releasing particles of “pigment”. Cells of the immune system are activated to clear these pigment particles, causing severe inflammation and blockage of the eyes fluid outflow pathway. Two gene defects are known to cause the release of pigmented particles, resulting in glaucoma. However, there are other unknown factors that contribute to pigmentary glaucoma. This research project will identify one of these previously unknown factors. A unique form of a protein that is expressed in the eye only when pigmentary glaucoma develops has been identified. This protein stimulates inflammation and destroys the fluid outflow system. Completion of this project will identify a new and novel target for treating pigmentary glaucoma.
Related Grants
National Glaucoma Research
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
National Glaucoma Research
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester